Kübra Çelik

Dr. Kübra Çelik


Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 July 2020 in Materials
Verified
Journal Article
Open access
PDF file
Esra Cansever MutluEsra Cansever Mutlu
Esra Cansever Mutlu
ÖKÖzge Kaya
Özge Kaya
MWMatthew Wood
Matthew Wood
IMImre Mager
Imre Mager
KÇKübra Çelik
Kübra Çelik
JBJale Odabaşı Bağcı
Jale Odabaşı Bağcı
Immature dendritic cells (IDc), ‘dexosomes’, are promising natural nanomaterials for cancer diagnose and therapy. Dexosomes were isolated purely from small-scale-up production by using t25-cell-culture flasks. Total RNA was measured as 1.43 ± 0.33 ng/106 cell. Despite the fact that they possessed a surface that is highly abundant in protein, this did not become a significant effect on the DOX loading amount. Ultrasonication was used for doxorubicin (DOX) loading into the IDc dexosomes. In accordance with the literature, three candidate DOX formulations were designed as IC50 values; dExoIII, 1.8 µg/mL, dExoII, 1.2 µg/mL, and dExoI, 0.6 µg/mL, respectively. Formulations were evaluated by MTT test against highly metastatic A549 (CCL-185; ATTC) cell line. Confocal images of unloaded (naïve) were obtained by CellMaskTM membrane staining before DOX loading. Although, dexosome membranes were highly durable subsequent to ultrasonication, it was observed that dexosomes could not be stable above 70 °C during the SEM-image analyses. dExoIII displayed sustained release profile. It was found that dynamic light scattering (DLS) and nanoparticle tracking analysis (NTA) results were in good agreement with each other. Zeta potentials of loaded dexosomes have approximately between −15 to −20 mV; and, their sizes are 150 nm even after ultrasonication. IDcJAWSII dexosomes can be able to be utilized as the “BioNanoMaterial” after DOX loading via ultrasonication technique.

3 April 2026
Verified
Book Chapter
Closed access
KÇKübra Çelik
Kübra Çelik
Alzheimer hastalığı (AH), ilerleyici hafıza kaybı ve bilişsel bozulma ile karakterize, demansın en yaygın formudur. Hastalığın temelinde amiloid-β birikimi, tau proteinlerinin anormal fosforilasyonu, kolinerjik yetersizlik, oksidatif hasar ve nöroinflamasyon yer alır. Bu patolojik süreçler özellikle hipokampus ve kortekste sinaptik işlevin bozulmasına ve nöron kayıplarına neden olur. Yaşlanan nüfusla birlikte AH insidansının artması, hastalığın biyolojik mekanizmalarını aydınlatmak ve etkili tedaviler geliştirmek amacıyla deneysel hayvan modellerine olan ihtiyacı artırmıştır. Mevcut modeller, Alzheimer patolojisinin farklı yönlerini taklit ederek araştırmalara önemli katkılar sağlamaktadır. Transgenik fare ve sıçan modelleri, APP, PSEN ve MAPT mutasyonları aracılığıyla Aβ birikimi, tau fosforilasyonu ve bilişsel bozulmayı kapsamlı biçimde yansıtır. Aβ veya tau enjeksiyonuna dayalı modeller kısa sürede plak benzeri patoloji oluştururken; D-galaktoz ve AlCl₃ gibi kimyasal modeller yaşlanma ve oksidatif stres süreçlerini öne çıkarır. Zebrafish gibi küçük omurgalılar erken dönem patolojileri incelemede avantaj sunarken, doğal ve hızlandırılmış yaşlanma modelleri herhangi bir müdahale olmaksızın yaşa bağlı bilişsel gerilemeyi taklit eder. Her model yalnızca belirli bir patolojik süreci temsil ettiğinden, tek bir model AH’nin tüm klinik ve nöropatolojik spektrumunu tam olarak yansıtamaz. Buna rağmen bu modeller, hastalığın mekanizmalarını anlamada ve terapötik stratejilerin geliştirilmesinde temel araçlar olmaya devam etmektedir. Alzheimer's disease (AD) is the most common form of dementia, characterized by progressive memory loss and cognitive impairment. The underlying pathologies include amyloid-β accumulation, abnormal phosphorylation of tau proteins, cholinergic insufficiency, oxidative damage, and neuroinflammation. These pathological processes cause impaired synaptic function and neuronal loss, particularly in the hippocampus and cortex. The increasing incidence of AD with an aging population has heightened the need for experimental animal models to elucidate the biological mechanisms of the disease and develop effective treatments. Current models provide important contributions to research by mimicking different aspects of Alzheimer's pathology. Transgenic mouse and rat models comprehensively reflect Aβ accumulation, tau phosphorylation, and cognitive impairment through APP, PSEN, and MAPT mutations. Models based on Aβ or tau injection rapidly generate plaque-like pathology, while chemical models such as D-galactose and AlCl₃ highlight aging and oxidative stress processes. Small vertebrates such as zebrafish offer advantages in studying early-stage pathologies, while natural and accelerated aging models mimic age-related cognitive decline without any intervention. Since each model represents only a specific pathological process, no single model can fully reflect the entire clinical and neuropathological spectrum of AD. Nevertheless, these models continue to serve as fundamental tools for understanding the mechanisms of the disease and developing therapeutic strategies.